Abbott Labs (ABT) PT Raised to $112 at Morgan Stanley; 'BinaxNOW May Change the Game'
Tweet Send to a Friend
Morgan Stanley analyst David Lewis raised the price target on Abbott Labs (NYSE: ABT) to $112.00 (from $106.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
